IL159153A0 - Methods for testing drugs for treating or preventing diseases such as hyperlipidemia - Google Patents

Methods for testing drugs for treating or preventing diseases such as hyperlipidemia

Info

Publication number
IL159153A0
IL159153A0 IL15915302A IL15915302A IL159153A0 IL 159153 A0 IL159153 A0 IL 159153A0 IL 15915302 A IL15915302 A IL 15915302A IL 15915302 A IL15915302 A IL 15915302A IL 159153 A0 IL159153 A0 IL 159153A0
Authority
IL
Israel
Prior art keywords
hyperlipidemia
treating
methods
preventing diseases
testing drugs
Prior art date
Application number
IL15915302A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL159153A0 publication Critical patent/IL159153A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL15915302A 2001-06-08 2002-06-07 Methods for testing drugs for treating or preventing diseases such as hyperlipidemia IL159153A0 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP2001173758 2001-06-08
JP2001178548 2001-06-13
JP2001213334 2001-07-13
JP2001300715 2001-09-28
JP2001300716 2001-09-28
JP2001357037 2001-11-22
JP2001384103 2001-12-18
JP2002103583 2002-04-05
PCT/JP2002/005657 WO2002101039A1 (fr) 2001-06-08 2002-06-07 Procede de test de medicament destine a traiter ou a prevenir des maladies telles que l'hyperlipemie

Publications (1)

Publication Number Publication Date
IL159153A0 true IL159153A0 (en) 2004-06-01

Family

ID=27573757

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15915302A IL159153A0 (en) 2001-06-08 2002-06-07 Methods for testing drugs for treating or preventing diseases such as hyperlipidemia

Country Status (4)

Country Link
EP (1) EP1403367A4 (fr)
CA (1) CA2450022A1 (fr)
IL (1) IL159153A0 (fr)
WO (1) WO2002101039A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
KR20070007894A (ko) * 2004-04-05 2007-01-16 아스텔라스세이야쿠 가부시키가이샤 항비만약
US7785903B2 (en) 2004-04-09 2010-08-31 Genentech, Inc. Variable domain library and uses
SI1771474T1 (sl) 2004-07-20 2010-06-30 Genentech Inc Inhibitorji angiopoetinu podobnega proteina kombinacije in njihova uporaba
US8604185B2 (en) 2004-07-20 2013-12-10 Genentech, Inc. Inhibitors of angiopoietin-like 4 protein, combinations, and their use
ZA200701184B (en) 2004-07-20 2008-07-30 Genentech Inc Compositions and methods of using angiopoietin-like 4 protein
JP5484063B2 (ja) * 2006-12-08 2014-05-07 レキシコン ファーマシューティカルズ インコーポレーテッド Ａｎｇｐｔｌ３に対するモノクローナル抗体
US8653047B2 (en) 2010-01-08 2014-02-18 Isis Pharmaceuticals, Inc. Modulation of angiopoietin-like 3 expression
AU2015200969A1 (en) * 2010-01-08 2015-03-19 Ionis Pharmaceuticals, Inc. Modulation of angiopoietin-like 3 expression
PL2992098T3 (pl) 2013-05-01 2019-09-30 Ionis Pharmaceuticals, Inc. Kompozycje i sposoby modulowania ekspresji hbv i ttr
US20170037409A1 (en) 2013-12-24 2017-02-09 Ionis Pharmaceuticals, Inc. Modulation of angiopoietin-like 3 expression
ES2844593T3 (es) 2014-05-01 2021-07-22 Ionis Pharmaceuticals Inc Composiciones y procedimientos para modular la expresión de la angiopoyetina de tipo 3
BR112018003291A2 (pt) 2015-11-06 2018-09-25 Ionis Pharmaceuticals, Inc. modulando a expressão da apolipoproteina (a)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053753A2 (fr) * 1999-03-08 2000-09-14 Genentech, Inc. Activation ou inhibition de l'angiogenese et de la cardiovascularisation
AU3661199A (en) * 1998-04-27 1999-11-16 Zymogenetics Inc. Novel polypeptide growth factors and materials and methods for making them
AU4643699A (en) * 1998-06-24 2000-01-10 Compugen Ltd. Angiopoietin-like growth factor sequences
JP2000300263A (ja) * 1999-04-14 2000-10-31 Herikkusu Kenkyusho:Kk 血管新生に関連するタンパク質「４１０」および「ｎｅｗ」、ならびに該タンパク質をコードする遺伝子
EP1239050A4 (fr) * 1999-12-09 2004-07-21 Sankyo Co Procede d'essai d'agent curatif ou preventif de l'hyperlipemie

Also Published As

Publication number Publication date
WO2002101039A1 (fr) 2002-12-19
EP1403367A4 (fr) 2005-08-17
CA2450022A1 (fr) 2002-12-19
EP1403367A1 (fr) 2004-03-31

Similar Documents

Publication Publication Date Title
IL160933A0 (en) Methods and compositions for treating ?cap associated diseases
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
SI3143995T1 (sl) Derivat rapamicina za zdravljenje pljučnega raka
HUP0400314A3 (en) Pharmaceutical combinations for the treatment of cancer
AU2002303283A8 (en) Methods for treating drug addiction
HK1079993A1 (en) Drugs for treating vascular diseases
EP1465968A4 (fr) Procedes de traitement de distillat desodorisant
IL159153A0 (en) Methods for testing drugs for treating or preventing diseases such as hyperlipidemia
HUP0401612A3 (en) Pharmaceutical composition suitable for treating diabetes
EP1450820A4 (fr) Methode de traitement et de prevention de maladies inflammatoires
EP1448193A4 (fr) Composes therapeutiques pour le traitement d'etats dyslipidemiques
EP1422743A4 (fr) Systeme de traitement
HUP0401042A3 (en) Pharmaceutical compositions suitable for treating primary insomnia
EP1401377A4 (fr) Methodes de traitement du cancer
EP1458694A4 (fr) Composes therapeutiques destines au traitement d'etats dyslipidemiques
GB0127384D0 (en) Well treatment system
HUP0200253A2 (en) Pharmaceutical compositions for combination therapy
AUPR520701A0 (en) Herbal composition for the treatment of drug addiction
AU2002331279A1 (en) Pharmaceutical composition for treating hypercholesterolaemia
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease
GB2397018B (en) Combination therapy for treating disease
EP1490048A4 (fr) Composition pharmaceutique permettant d'empecher ou de traiter les maladies respiratoires
AU2002238991A1 (en) Novel drugs for preventing/treating immunopathic diseases
GB0123063D0 (en) Compositions for therapy
GB0128004D0 (en) System for treatment